PIPELINE

MORE
IVMED-80 (Keratoconus orphan drug)
IVMED-70 (Glaucoma MIGS device)
IVMED 10/20 (No eye s)
Broad spectrum flu peptide therapeutic
MEK inhibitor
CDK4/6 inhibitor (Breast cancer)
pan-HER inhibitor (Non-small cell lung cancer)
DPP-4 inhibitors (Type 2 Diabetes mellitus)
ALK inhibitor (Non-small cell lung cancer)

GLOBAL C&D PROJECT PARTICIPANTS




    • Aagami
    • Bionaturis
    • Allovate
    • Cellmid
    • Amorchem
    • Crossbeta Biosciences
    • Aurigene
    • Intrommune Therapeutics
    • Kissei Pharmaceutical
    • MyeloRx
    • Genefrontier
    • Coarebiotech
    • Immune Biosolutions
    • NEOMED
    • APIM Therapeutics
    • Ulster University
    • Southern Research
    • UCL
    • Atrin Pharmaceuticals
    • LTTO
    • AVEO Pharmaceuticals
    • ULB
    • Amunix
    • University of Namur
    • iVeena
    • Valin Technologies
    • MBM Sciencebridge
    • Wiborg
    • Aronora, Inc.
    • Lipopharma